FDA Inspection 1199962 — Fisher Wallace Laboratories Inc.

Fisher Wallace Laboratories Inc. — FEI 3006258094

The FDA completed an inspection of Fisher Wallace Laboratories Inc. on March 15, 2023 in Brooklyn, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 15, 2023
Fiscal Year
2023
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Brooklyn, NY (United States)